Want to take quizzes and track your credits?
Decreases in the cost of DNA sequencing have enabled substantial progress in fields ranging from archaeology and evolution to basic biomedical science. Concomitantly, there have been calls for routine genome-scale sequencing of healthy individuals in hopes of discovering clinically important information. For example, discovery of a high risk of breast and ovarian cancer due to a BRCA1/2 mutation can enable aggressive surveillance or risk-reducing surgery.
Sign in to take quiz and track your certificates
Corresponding Author: James P. Evans, MD, PhD, Departments of Genetics and Medicine, CB #7264, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7264 (firstname.lastname@example.org).
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Berg reports being a funded investigator on the National Human Genome Research Institute–funded GeneScreen project, which is investigating the potential use of genomic screening of a small panel of genes in generally healthy adults. No other disclosures were reported.
You currently have no searches saved.